Ganciclovir derivatives for modulating innate and adaptive immunity and for use in immunotherapy
2017
Abstract
Compositions and methods for modulating innate and adaptive immunity and for use in immunotherapy are disclosed. In particular, the invention relates to novel ganciclovir derivatives and methods of using them for the treatment of immune-related disorders, including inflammation, autoimmunity, and infections, and neurological disorders, and cancer.
Details
Title
Ganciclovir derivatives for modulating innate and adaptive immunity and for use in immunotherapy
Author(s)
Burai, Ritwik ; Lashuel, Hilal A ; Mathur, Vidhu ; Wyss-Coray, Anton
Date
2017
Keywords
Other identifier(s)
EPO Family ID: 58157430
Patent number(s)
US9809597 (B2)
US2017050967 (A1)
US2017050967 (A1)
Additional link
URL
Laboratories
LMNN
Record Appears in
Scientific production and competences > SV - School of Life Sciences > BMI - Brain Mind Institute > LMNN - Laboratory of Molecular Neurobiology and Neuroproteomics
Work produced at EPFL
Patents
Work produced at EPFL
Patents
Record creation date
2017-12-01